Abeona Therapeutics Inc.

NASDAQ:ABEO

Biotechnology

Healthcare
$2.73 +1.06%

+$0.06 today

Market cap
$156.01M
Beta
1.35
P/E (TTM)
4.9
EPS (TTM)
$1.17
52W Low $4.00High $7.54

Volume 1.71M

Average 1.12M

Balance Sheet

Inspect the capital base behind the business.

Assets

$219.57M

FY 2025 · Annual

+101.6% YoY

Liabilities

$60.35M

FY 2025 · Annual

-7.0% YoY

Equity

$159.22M

FY 2025 · Annual

+261.6% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents32.94M14.22M14.47M23.36M78.44M
Short-term Investments12.09M37.93M37.75M74.36M112.97M
Net Receivables3M188K2.44M1.65M6.72M
Inventory00005.49M
Other Current Assets891K762K338K1.48M1.29M
Total Current Assets56.29M53.1M55.74M100.85M204.91M
Property, Plant & Equipment (Net)21.74M11.07M7.99M7.98M13.88M
Goodwill00000
Intangible Assets1.38M0000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets168K43K277K96K781K
Total Non-current Assets23.29M11.12M8.27M8.08M14.66M
Total Assets79.59M64.21M64M108.93M219.57M
Account Payables4.33M1.81M1.86M3.44M7.89M
Short-term Debt0005.93M12.22M
Tax Payables00000
Deferred Revenue296K0000
Other Current Liabilities1.79M2.8M3.69M4.46M5.64M
Total Current Liabilities16.62M7.78M13.42M16.59M29.57M
Long-term Debt00013.04M7.81M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities13.04M23.82M31.35M32.01M18.9M
Total Non-current Liabilities20.6M29.67M35.75M48.31M30.78M
Total Liabilities37.22M37.45M49.18M64.9M60.35M
Common Stock1.47M177K265K457K550K
Retained Earnings(655.64M)(695.34M)(749.52M)(813.26M)(742.08M)
Accumulated OCI(27K)(129K)(66K)8K138K
Other Stockholders Equity00000
Minority Interest00000
Total Equity42.37M26.76M14.83M44.03M159.22M
Total Debt9.38M7.63M5.4M23.05M24.97M
Net Debt(23.56M)(6.59M)(9.07M)(309K)(53.47M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$61.4M
Short-term Investments$106.9M
Receivables$6.7M
Inventory$6.1M
Other Current$2.0M
Total Current Assets$183.0M
PP&E (Net)$14.7M
Other Non-current$827.0K
Total Non-current Assets$15.5M
Total Assets$198.5M

Analysis

Selected assets total $198.5M for Latest. The largest visible component is Short-term Investments at $106.9M, about 53.9% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13G/ASC 13G/A filingNov 13, 2026
SC 13G/ASC 13G/A filingNov 12, 2026
10-QQuarterly reportNov 9, 2026
8-KCurrent reportNov 9, 2026
8-KCurrent reportNov 9, 2026

How much cash does ABEO have?

Abeona Therapeutics Inc. (ABEO) reported $78.44M in cash and equivalents in fiscal 2025.

How much debt does ABEO carry?

Abeona Therapeutics Inc. (ABEO) reported $24.97M of total debt, with net debt of -$53.47M.